Alwin Capital
China-based venture capital firm specializing in early-stage life science investments, including biotech, gene therapy, cell therapy, and diagnostics.
Beijing, China · 4+ investments · 3 portfolio companies
- Headquarters
- Beijing, China
- Founded
- 2015
- Website
- alwincapital.com
- AUM
- $500.0M
- Portfolio Companies
- 3
- Total Investments
- 4
- Last Investment
- Apr 2021
- Geographic Focus
- China
Investment Thesis
Alwin Capital is a Venture Capital firm based in Beijing, China. It has made 4 investments, including Immorna, Synbio Technologies and EdiGene. Focus areas include Biotech.
Portfolio3
Co-investors20
Sign up to view co-investors
20 co-investors across 21 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×17 · Corporate VC ×1 · Private Equity ×1 · 17 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/alwin-capital"><img src="https://indexed.vc/api/badge/investor/alwin-capital" alt="Alwin Capital on Indexed.vc" width="260" height="76" /></a>